A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Institution: Assurex Health (United States)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W45763398